Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis

Clinical and Experimental Metastasis

Volumn 30, Issue 3, 2013, Pages 317-332

  Fernández Vallone, Valeria B ^a   Hofer, Erica L ^a   Choi, Hosoon ^b   Bordenave, Raúl H ^c   Batagelj, Emilio ^d   Feldman, Leonardo ^e   La Russa, Vincent ^f   Caramutti, Daniela ^a   Dimase, Federico ^d   Labovsky, Vivian ^a   Martínez, Leandro M ^a   Chasseing, Norma A ^a  

^a Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

^c Hospital Iriarte   (Argentina)

^d Central Militar Hospital   (Argentina)

^e HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Bone marrow; Cancer; Mesenchymal stem cell; Plasticity

Indexed keywords

CD146 ANTIGEN; DICKKOPF 1 PROTEIN;

ADIPOGENESIS; ADULT; ADVANCED CANCER; AGED; ANTIGEN EXPRESSION; ARTICLE; BONE ATROPHY; BONE DEVELOPMENT; BONE METASTASIS; BREAST CANCER; CANCER PATIENT; CELL DIFFERENTIATION; CHONDROGENESIS; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG CANCER; MESENCHYMAL STEM CELL; PROTEIN BLOOD LEVEL; BONE MARROW; BONE TUMOR; BREAST TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; LUNG TUMOR; MESENCHYMAL STROMA CELL; METASTASIS; OSTEOLYSIS; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

BONE MARROW; BONE NEOPLASMS; BREAST NEOPLASMS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MESENCHYMAL STROMAL CELLS; OSTEOLYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

MLCS; MLOWN;

EID: 84875770209     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-012-9539-4     Document Type: Article

References (71)

1. Del Fattore A, Capannolo M, Rucci N (2010) Bone and bone marrow: the same organ. Arch Biochem Biophys 503(1):28-34
2. Muguruma Y et al (2006) Reconstitution of the functional human hematopoietic microenvironment derived from human mesenchymal stem cells in the murine bone marrow compartment. Blood 107(5):1878-1887
3. Pogoda P et al (2005) Bone remodeling: new aspects of a key process that controls skeletal maintenance and repair. Osteoporos Int 16(Suppl 2):S18-S24
4. Compston JE (2002) Bone marrow and bone: a functional unit. J Endocrinol 173(3):387-394
5. Yin T, Li L (2006) The stem cell niches in bone. J Clin Invest 116(5):1195-1201
6. Doan PL, Chute JP (2012) The vascular niche: home for normal and malignant hematopoietic stem cells. Leukemia 26(1):54-62
7. Wang LD, Wagers AJ (2011) Dynamic niches in the origination and differentiation of haematopoietic stem cells. Nat Rev Mol Cell Biol 12(10):643-655
8. Roodman GD (2004) Mechanisms of bone metastasis. N Engl J Med 350(16):1655-1664
9. Ooi LL et al (2011) The bone remodeling environment is a factor in breast cancer bone metastasis. Bone 48(1):66-70
10. Onishi T et al (2010) Future directions of bone-targeted therapy for metastatic breast cancer. Nat Rev Clin Oncol 7(11):641-651
11. Luis-Ravelo D et al (2011) Tumor-stromal interactions of the bone microenvironment: in vitro findings and potential in vivo relevance in metastatic lung cancer models. Clin Exp Metastasis
12. Guise TA et al (2005) Molecular mechanisms of breast cancer metastases to bone. Clin Breast Cancer 5 Suppl (2):S46-S53
13. Chantrain CF et al (2008) Bone marrow microenvironment and tumor progression. Cancer Microenviron 1(1):23-35
14. Hsu YL et al (2011) Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2/Snail signaling pathway. J Biol Chem 286(43):37335-37346
15. Coleman RE et al (2010) Metastasis and bone loss: advancing treatment and prevention. Cancer Treat Rev 36(8):615-620
16. Rosen LS et al (2003) Zoledronic acid versus placebo in the treatment of skeletal metastases in patients with lung cancer and other solid tumors: a phase III, double-blind, randomized trial - the zoledronic acid lung cancer and other solid tumors study group. J Clin Oncol 21(16):3150-3157
17. Kvale PA, Simoff M, Prakash UB (2003) Lung cancer. Palliative care. Chest 123(1 Suppl):284S-311S
18. Papadakis SA et al (2004) The development of bone metastases as the first sign of metastatic spread in patients with primary solid tumours. Int Orthop 28(2):102-105
19. Mercer RR, Mastro AM (2005) Cytokines secreted by bone-metastatic breast cancer cells alter the expression pattern of f-actin and reduce focal adhesion plaques in osteoblasts through PI3K. Exp Cell Res 310(2):270-281
20. Nannuru KC, Singh RK (2010) Tumor-stromal interactions in bone metastasis. Curr Osteoporos Rep 8(2):105-113
21. Fromigue O et al (2001) Breast cancer cells release factors that induced apoptosis in human bone marrow stromal cells. J Bone Miner Res 16(9):1600-1610
22. Atkins GJ et al (2003) RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18(6):1088-1098
23. Voorzanger-Rousselot N et al (2009) Assessment of circulating Dickkopf-1 with a new two-site immunoassay in healthy subjects and women with breast cancer and bone metastases. Calcif Tissue Int 84(5):348-354
24. Sheng SL et al (2009) Clinical significance and prognostic value of serum Dickkopf-1 concentrations in patients with lung cancer. Clin Chem 55(9):1656-1664
25. Yamabuki T et al (2007) Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas. Cancer Res 67(6):2517-2525
26. Majumdar MK et al (2000) Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 9(6):841-848
27. Ramalho AC et al (2001) Effect of oestradiol on cytokine production in immortalized human marrow stromal cell lines. Cytokine 16(4):126-130
28. Kim DH et al (2005) Gene expression profile of cytokine and growth factor during differentiation of bone marrow-derived mesenchymal stem cell. Cytokine 31(2):119-126
29. Fromigue O, Modrowski D, Marie PJ (2004) Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta. Curr Pharm Des 10(21):2593-2603
30. Rose AA, Siegel PM (2006) Breast cancer-derived factors facilitate osteolytic bone metastasis. Bull Cancer 93(9):931-943
31. Bonyadi M et al (2003) Mesenchymal progenitor self-renewal deficiency leads to age-dependent osteoporosis in Sca-1/Ly-6A null mice. Proc Natl Acad Sci USA 100(10):5840-5845
32. Beresford JN (1989) Osteogenic stem cells and the stromal system of bone and marrow. Clin Orthop Relat Res 240:270-280
33. Gregory CA et al (2005) Dkk-1-derived synthetic peptides and lithium chloride for the control and recovery of adult stem cells from bone marrow. J Biol Chem 280(3):2309-2323
34. Friedenstein AJ (1961) Osteogenetic activity of transplanted transitional epithelium. Acta Anat (Basel) 45:31-59
35. Bruder SP, Jaiswal N, Haynesworth SE (1997) Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64(2):278-294
36. Baksh D, Song L, Tuan RS (2004) Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 83:301-16
37. Pittenger MF et al (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284(5411):143-147
38. Muraglia A, Cancedda R, Quarto R (2000) Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 113(Pt 7):1161-1166
39. Tormin A et al (2011) CD146 expression on primary non-hematopoietic bone marrow stem cells correlates to in situ localization. Blood 117(19):5067-5077
40. Russell KC et al (2010) In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 28(4):788-798
41. Castro-Malaspina H et al (1980) Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 56(2):289-301
42. Labovsky V et al (2010) Cardiomyogenic differentiation of human bone marrow mesenchymal cells: role of cardiac extract from neonatal rat cardiomyocytes. Differentiation 79(2):93-101
43. Hofer EL et al (2010) Mesenchymal stromal cells, colony-forming unit fibroblasts, from bone marrow of untreated advanced breast and lung cancer patients suppress fibroblast colony formation from healthy marrow. Stem Cells Dev 19(3):359-370
44. Dominici M et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-317
45. Tripodo C et al (2009) CD146(+) bone marrow osteoprogenitors increase in the advanced stages of primary myelofibrosis. Haematologica 94(1):127-130
46. Yoneda T, Hiraga T (2005) Crosstalk between cancer cells and bone microenvironment in bone metastasis. Biochem Biophys Res Commun 328(3):679-687
47. Fierro FA et al (2004) Marrow-derived mesenchymal stem cells: role in epithelial tumor cell determination. Clin Exp Metastasis 21(4):313-319
48. Hombauer H, Minguell JJ (2000) Selective interactions between epithelial tumour cells and bone marrow mesenchymal stem cells. Br J Cancer 82(7):1290-1296
49. Karnoub AE et al (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449(7162):557-563
50. Sasser AK et al (2007) Human bone marrow stromal cells enhance breast cancer cell growth rates in a cell line-dependent manner when evaluated in 3D tumor environments. Cancer Lett 254(2):255-264
51. Molloy AP et al (2009) Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int J Cancer 124(2):326-332
52. Catena R et al (2011) PDGFR signaling blockade in marrow stroma impairs lung cancer bone metastasis. Cancer Res 71(1):164-174
53. Muraglia A et al (2003) Formation of a chondro-osseous rudiment in micromass cultures of human bone-marrow stromal cells. J Cell Sci 116(Pt 14):2949-2955
54. Pevsner-Fischer MLS, Zipori D (2011) The origins of mesenchymal stromal cell heterogeneity. Stem Cell Rev 7(3):560-568
55. Jaiswal RK et al (2000) Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem 275(13):9645-9652
56. Sacchetti B et al (2007) Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell 131(2):324-336
57. Pinzone JJ et al (2009) The role of Dickkopf-1 in bone development, homeostasis, and disease. Blood 113(3):517-525
58. Tian E et al (2003) The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 349(26):2483-2494
59. Menezes ME et al (2011) Dickkopf1: a tumor suppressor or metastasis promoter? Int J Cancer 130:1477-1483
60. Scutt A, Bertram P (1999) Basic fibroblast growth factor in the presence of dexamethasone stimulates colony formation, expansion, and osteoblastic differentiation by rat bone marrow stromal cells. Calcif Tissue Int 64(1):69-77
61. Huang Z et al (2010) Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 51(3):305-310
62. Hildner F et al (2010) FGF-2 abolishes the chondrogenic effect of combined BMP-6 and TGF-beta in human adipose derived stem cells. J Biomed Mater Res A 94(3):978-987
63. Weiss S et al (2010) Impact of growth factors and PTHrP on early and late chondrogenic differentiation of human mesenchymal stem cells. J Cell Physiol 223(1):84-93
64. Hofer EL et al (2005) Alteration on the expression of IL-1, PDGF, TGF-beta, EGF, and FGF receptors and c-Fos and c-Myc proteins in bone marrow mesenchymal stroma cells from advanced untreated lung and breast cancer patients. Stem Cells Dev 14(5):587-594
65. Hofer EL, Bordenave RH, Bullorsky EO, Belloc DG, Chasseing NA (2002) Immunohistochemical characterization of bone marrow fibroblast from untreated advanced lung and breast cancer patients compared to normal controls. Blood 100:187b
66. Baek KH et al (2010) Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 87(3):226-235
67. de Cavanagh EM et al (2002) Higher oxidation and lower antioxidant levels in peripheral blood plasma and bone marrow plasma from advanced cancer patients. Cancer 94(12):3247-3251
68. Felka T et al (2009) Hypoxia reduces the inhibitory effect of IL-1beta on chondrogenic differentiation of FCS-free expanded MSC. Osteoarthritis Cartilage 17(10):1368-1376
69. Vu TH, Werb Z (2000) Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14(17):2123-2133
70. Hofer E, Chudzinski-Tavassi AM, Bullorsky OE, Bordenave RH, Chasseing NA (2002) MMPs and tissue inhibitors in conditioned mediums from bone marrow CFU-F of advanced lung and breast cancer patients. Hematol J 81(2):80-85
71. Kasper G et al (2007) Matrix metalloprotease activity is an essential link between mechanical stimulus and mesenchymal stem cell behavior. Stem Cells 25(8):1985-1994